REQUEST A DEMO
Total
USD $0.00
Search more companies

Sven Biolabs S.R.O. (Czech Republic)

Main Activities: Wholesale Trade
Full name: Sven Biolabs S.R.O. Profile Updated: April 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sven Biolabs S.R.O. is based in Czech Republic, with the head office in Prague. It operates in the Wholesale Trade industry. The company was established on July 23, 2010. It currently has a total number of 10 - 19 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 101.62% in 2025. Its’ total assets recorded a growth of 16.35%. The net profit margin of Sven Biolabs S.R.O. increased by 4.85% in 2025.

Headquarters
Cerpadlova 1034/2
Prague; The City of Prague; Postal Code: 19000

Contact Details: Purchase the Sven Biolabs S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Sven Biolabs S.R.O. report to view the information.
Registered Capital:
Purchase the Sven Biolabs S.R.O. report to view the information.
Financial Auditors:
Purchase the Sven Biolabs S.R.O. report to view the information.
Incorporation Date:
July 23, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Sven Biolabs S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
101.62%
Total Operating Revenue
101.57%
Operating Profit
260.09%
EBITDA
151.32%
Net Profit/Loss for the Period
308.2%
Total Assets
16.35%
Total Equity
70.51%
Operating Profit Margin
5.3%
Net Profit Margin
4.85%
Return on Equity (ROE)
24.08%
Quick Ratio
0.68%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?